Uchino J, Nishida O, Takada N
Gan No Rinsho. 1986 Aug;32(10):1273-7.
Main primary sites of hepatic metastatic cancers were the stomach, colon, pancreas and esophagus. Those were found in 16.1% of 335 stomach cancer, 11.9% of 270 colon cancer, 27.1% of 70 pancreas cancer and 3.8% of 131 esophageal cancer at the time of operation. However, the metastatic lesions were resectable in 13%, 43%, 0% and 20%, respectively. Prognosis after hepatectomy was favorable only in colon cancer. 7 of 13 patients who underwent resection of the colon cancer and hepatic metastases are still surviving. The others all died. In inoperable cases, chemotherapy, especially intrahepatic arterial infusion, prolonged the survival time for months.
肝转移癌的主要原发部位是胃、结肠、胰腺和食管。在335例胃癌患者中,有16.1%在手术时发现肝转移;270例结肠癌患者中,有11.9%;70例胰腺癌患者中,有27.1%;131例食管癌患者中,有3.8%。然而,转移灶的可切除率分别为13%、43%、0%和20%。肝切除术后仅结肠癌患者预后良好。13例接受结肠癌和肝转移灶切除的患者中有7例仍存活,其他患者均死亡。在无法手术的病例中,化疗,尤其是肝动脉内灌注化疗,可使生存时间延长数月。